Among the 106 adenosquamous lung carcinoma patients, 38 had elevated NSE levels, 50 elevated CEA, 58 elevated Cyfra21-1 and 16 elevated SCCA. The gene discussed is CEACAM5; the disease is adenosquamous lung carcinoma.